Glycyrrhetinic acid blocks SARS‐CoV‐2 infection by activating the cGAS‐STING signalling pathway

Traditional Chinese medicine (TCM) played an important role in controlling the COVID‐19 pandemic, but the scientific basis and its active ingredients are still weakly studied. This study aims to decipher the underlying anti‐SARS‐CoV‐2 mechanisms of glycyrrhetinic acid (GA).

• Publication year

  2024

• Venue

  British Journal of Pharmacology

• Publication date

  2024-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bph.16473PMID 38922702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative Computed Tomography Lung COVID Scores with Laboratory Markers: Utilization to Predict Rapid Progression and Monitor Longitudinal Changes in Patients with Coronavirus 2019 (COVID-19) Pneumonia

  2024cited by this paper
• The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

  2023cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2024

  2023cited by this paper
• The role of cGAS-STING signaling in pulmonary fibrosis and its therapeutic potential

  2023cited by this paper
• Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses

  2023cited by this paper
• Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial

  2023influential reference
• The mechanism of STING autoinhibition and activation.

  2023cited by this paper
• The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets

  2023cited by this paper
• SARS-CoV-2 variant biology: immune escape, transmission and fitness

  2023cited by this paper
• Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice

  2023cited by this paper
• The cGAS–STING pathway drives type I IFN immunopathology in COVID-19

  2022cited by this paper
• SARS-CoV-2 pathogenesis

  2022cited by this paper
• Activation of STING Based on Its Structural Features

  2022cited by this paper
• Planning experiments: Updated guidance on experimental design and analysis and their reporting III

  2022cited by this paper
• Protocol to induce and assess cGAS-STING pathway activation in vitro

  2022cited by this paper
• Involvement of the STING signaling in COVID-19

  2022cited by this paper
• Traditional Chinese medicine in COVID-19

  2021cited by this paper
• A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

  2021influential reference
• Pharmacological activation of STING blocks SARS-CoV-2 infection

  2021influential reference
• Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2

  2021cited by this paper
• Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019

  2021cited by this paper
• An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

  2021cited by this paper
• Radiological–pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?

  2021cited by this paper
• Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial

  2021influential reference
• Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection

  2021influential reference
• Roles of Emerging RNA-Binding Activity of cGAS in Innate Antiviral Response

  2021cited by this paper
• Licorice (Glycyrrhiza glabra) Extracts-Suitable Pharmacological Interventions for COVID-19? A Review

  2021cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?

  2020cited by this paper
• Medicinal Plants as Sources of Active Molecules Against COVID-19

  2020cited by this paper
• ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

  2020cited by this paper
• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*

  2020cited by this paper
• Analysis on herbal medicines utilized for treatment of COVID-19

  2020influential reference
• COVID-19 as a STING disorder with delayed over-secretion of interferon-beta

  2020cited by this paper
• Molecular mechanisms and cellular functions of cGAS–STING signalling

  2020cited by this paper
• Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

  2020cited by this paper
• A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research

  2020cited by this paper
• Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP–AMP

  2019cited by this paper
• Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

  2018cited by this paper
• Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA.

  2013cited by this paper
• Structure of STING bound to c-di-GMP Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System

  2012cited by this paper
• Innate recognition of viruses.

  2007cited by this paper

• Chemistry and Pharmacological Properties of Glycyrrhetinic Acid: A Review

  2026cites this paper
• Investigation of the pharmacological mechanisms of Denglao Qingguan decoction in inhibiting viral pneumonia through network pharmacology and in vitro laboratory validation

  2026cites this paper
• Pattern Recognition Receptors (PRRs) Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging PRR-Targeted Immunotherapies

  2025cites this paper
• Novel mechanism of Guizhi Jia Huangqi Decoction disrupting HBV lifecycle via cAMP/PKC/PKB axis beyond NTCP blockade.

  2025cites this paper
• STING agonists as antiviral agents.

  2025cites this paper
• Research progress on the metabolic transformation of Shenling Baizhu San under the influence of the gut microbiota

  2025cites this paper
• Rosmarinic Acid inhibits Pseudorabies Virus (PRV) infection by activating the cGAS-STING signaling pathway

  2025cites this paper
• Novel Glycyrrhetin Ureas Possessing 2-Hydroxy-3-enone A Ring: Modification, Anti-inflammatory Activity, and Targeted STING for the Remedy of Acute Kidney Injury

  2024cites this paper
• Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases

  2024cites this paper